Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2–negative advanced breast cancer from the United States, Europe, and Israel

Tài liệu có liên quan:

• Differences between physician and patient preferences for cancer treatments: A systematic review

  13 trang 179 0 0

• Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer

  6 trang 171 0 0

• Immune checkpoint inhibitors and their impact on liver enzymes and attenuation

  7 trang 150 0 0

• 2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France

  9 trang 136 0 0

• Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment – oxaliplatin subscale: A prospective cohort study

  12 trang 103 0 0

• LAP3 contributes to IFN-γ-induced arginine depletion and malignant transformation of bovine mammary epithelial cells

  19 trang 81 0 0

• Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating selected features of TGFβ inhibition

  17 trang 71 0 0

• Determinants of late-stage cervical cancer presentation in Ethiopia: A systematic review and meta-analysis

  9 trang 48 0 0

• Appropriate dose of regorafenib based on body weight of colorectal cancer patients: A retrospective cohort study

  9 trang 43 0 0

• Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer

  17 trang 43 0 0